[1]
2024. Assessment of Factors Affecting Therapeutic Response of the DPP-4 Inhibitor Sitagliptin in A Sample of Iraqi Type 2 Diabetic Patients. Al Mustansiriyah Journal of Pharmaceutical Sciences. 24, 3 (Jul. 2024), 311–319. DOI:https://doi.org/10.32947/ajps.v24i3.1082.